Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CNS drugs approved by the centralised European procedure: true innovation or dangerous stagnation?

× No keyword cloud information.

5 in total

1. Adjusting Europe's drug regulation to public health needs.

Authors: S Garattini; V Bertele
Journal: Lancet Date: 2001-07-07 Impact factor: 79.321

2. Regulatory issues in Europe.

Authors: C Barbui; G Guaiana; S Garattini
Journal: J Clin Psychopharmacol Date: 2001-12 Impact factor: 3.153

3. European Council waters down European Parliament's drug-regulatory legislation.

Authors: Silvio Garattini; Vittorio Bertele'; Luca Li Bassi
Journal: Lancet Date: 2003-11-22 Impact factor: 79.321

4. Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003.

Authors: Domenico Motola; Fabrizio De Ponti; Pasqualino Rossi; Nello Martini; Nicola Montanaro
Journal: Br J Clin Pharmacol Date: 2005-04 Impact factor: 4.335

5. Olanzapine on trial.

Authors: C Barbui
Journal: Am J Psychiatry Date: 1998-01 Impact factor: 18.112

5 in total

3 in total

1. EMA's reflection on placebo does not reflect patients' interests.

Authors: Vittorio Bertele'; Rita Banzi; Christian Gluud; Silvio Garattini
Journal: Eur J Clin Pharmacol Date: 2011-12-02 Impact factor: 2.953

2. EMA and FDA psychiatric drug trial guidelines: assessment of guideline development and trial design recommendations.

Authors: Kim Boesen; Peter C Gøtzsche; John P A Ioannidis
Journal: Epidemiol Psychiatr Sci Date: 2021-04-30 Impact factor: 6.892

3. A new approach to psychiatric drug approval in Europe.

Authors: Corrado Barbui; Irene Bighelli
Journal: PLoS Med Date: 2013-10-15 Impact factor: 11.069

3 in total